Side Area Image
Novita Healthcare Limited (ASX:NHL) is an Australian Medical Technology Company listed on the Australian Securities Exchange. Novita's core focus is the development of TALI Health and the TALI Technology.
1300 082 013

Board of Directors

HomeAbout UsBoard of Directors

Sue MacLeman

Non-Executive Chair

Mark Simari

Non-Executive Director

Jefferson Harcourt

Non-Executive Director

Sue has more than 30 years’ experience as a pharmaceutical, biotechnology and medical technology executive with senior roles in corporate, medical, commercial and business development.

Sue has served as CEO and Board member of several ASX and NASDAQ listed companies in the sector and is currently Chair – Novita Healthcare Ltd , Chair – Anatara Lifesciences (ASX:ANR), Chair – MTPConnect (Medical Technology and Pharmaceuticals Industry Innovation Growth Centre MTPII-GC Ltd), Non-Executive Director – Oventus Medical Ltd (ASX: OVN), and veski. Sue is also appointed to a number of academic and government advisory committees.

Her broad commercial experience is underpinned by graduate qualifications in pharmacy and post graduate qualifications in corporate governance, commercial law, business administration and marketing.

Mark Simari brings a wealth of corporate and management experience to the Novita Healthcare team. He has been responsible for a number of successful company re-births as well as the integration of several acquisitions applying his strong business acumen and hands on management philosophy.

With excellent networks in the health and aged care, banking, capital markets and financial services sectors Mark has proven capabilities across a diverse range of industries facing substantial challenges in demanding environments.

Mark’s background incorporates experience as a company secretary, financial advisor and stockbroker and as the owner of several enterprises with expertise in mergers and acquisitions, business re-structuring, building shareholder value and ASX small to mid cap listings.

As Managing Director and Corporate Executive for Paragon Care (2009), Mark was instrumental in turning the company around from potential administration to embarking on an acquisition program that is now capitalising on the high growth health and aged care sector as well as delivering shareholder returns.

Mr Harcourt has over 15 years of experience as a company director and founder of Grey Innovation, a cutting edge engineering and technology commercialisation company based in Melbourne, Australia.

Mr Harcourt has a Bachelor of Engineering (Honors) and has worked in a wide range of industry sectors including defence, automotive, consumer electronics, and medical devices. Grey collaborates with leading Australian universities and research organisations to translate leading edge technologies into market ready products. Mr Harcourt has brought over one hundred products to market in the past fifteen years, and these devices are sold under leading brand names around the world.

He works closely with his technical team, and is comfortable with complex technology and product development methodologies.  In 2014 Jefferson co-founded the Verde Foundation; a not-for-profit foundation to translate medical device research into investment ready propositions. He has also raised capital and created a number of spin out companies, sits on a number of company boards, and is committed to helping create successful high-tech companies.